GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients With Atrial Fibrillation (Phase II/III - EU/EEA Member States)
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients With Atrial Fibrillation (Phase II/III - EU/EEA Member States)
In this part of the Registry Program patients with non-valvular atrial fibrillation (AF) at risk for stroke are enrolled to characterize the target population and to collect real world data on important outcome events. For administrative purposes the study is divided into two protocol numbers: 1160.129 for non-EU (European Union) and non-EEA (European Economic Area) countries, and 1160.136 for EU and EEA countries. The total number of patients enrolled in both protocols is estimated to be 48,000 patients, and all these patients will be included in the data analysis for study 1160.129.
Inclusion criteria:
Other inclusion criteria apply.
Exclusion criteria:
Bouge/Namur, 5004, Belgium
Bour-en-Bresse, 01012, France
Nïmes, 30032, France
Bad Neustadt/Saale, 97616, Germany
Essen, 45122, Germany
Coppitto (AQ), 67100, Italy
Montepulciano Senese (SI), 53045, Italy
Sesto S.Giovanni (MI), 20090, Italy
Sittard - Geleen, 6162 BG, Netherlands
El Palmar - Murcia, 30120, Spain
Jerez de La Frontera - Cádiz, 11407, Spain
Leganes - Madrid, 28911, Spain
Marbella . Málaga, 29603, Spain
Saint Just, Penzance, TR19 7HX, United Kingdom
Tyne-and-Wear, NE34 0PL, United Kingdom
Wansford, Peterborough, PE8 6PL, United Kingdom
Westcliffe-on-Sea, SS0 0RY, United Kingdom